World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
79
Citations
24808
World Ranking
1633
National Ranking
752

Medicine

D-Index
82
Citations
27568
World Ranking
16007
National Ranking
8054

Overview

Hans Peter Kiem is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research spans multiple fields, predominantly in biochemistry, genetics, molecular biology, and medicine. Within these broad areas, Kiem's work focuses on molecular biology, genetics, oncology, immunology, and hematology.

Their studies have largely concentrated on topics such as CAR-T cell therapy research, virus-based gene therapy research, CRISPR and genetic engineering, RNA interference and gene delivery, immune cell function and interaction, hematopoietic stem cell transplantation, and T-cell and B-cell immunology.

Frequent publication venues for Kiem's work include Blood with 29 publications, Molecular Therapy - Methods & Clinical Development with 15, Molecular Therapy with 12, Blood Advances with 11, and Transplantation and Cellular Therapy with 6.

Some of the notable recent papers authored or co-authored by Kiem include:

  • SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues, 2020, Cell
  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021, 2021, Nature Medicine
  • Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy, 2020, Nature Communications
  • Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies, 2020, Blood
  • In vivo HSC prime editing rescues Sickle Cell Disease in a mouse model, 2023, Blood

Hans Peter Kiem collaborates frequently with several co-authors, including Stefan Radtke, David G. Maloney, Jordan Gauthier, Cameron J. Turtle, and Mazyar Shadman.

Best Publications

  • SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.

    Carly G.K. Ziegler;Samuel J. Allon;Sarah K. Nyquist;Ian M. Mbano

  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

    Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts

    James J.H. Chong;Xiulan Yang;Creighton W. Don;Elina Minami

  • Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

    Ingo G H Schmidt-Wolf;Robert S. Negrin;Hans Peter Kiem;Karl G. Blume

  • Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.

    Rainer Storb;Cong Yu;John L. Wagner;H. Joachim Deeg

  • Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

    Mary E D Flowers;Yoshihiro Inamoto;Paul A. Carpenter;Stephanie J. Lee

  • Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal

    Iman Fares;Jalila Chagraoui;Yves Gareau;Stéphane Gingras

  • International AIDS Society global scientific strategy: towards an HIV cure 2016

    Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich

  • Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.

    Kevin A. Hay;Kevin A. Hay;Jordan Gauthier;Alexandre V. Hirayama;Jenna M. Voutsinas

  • Improved Gene Transfer Into Baboon Marrow Repopulating Cells Using Recombinant Human Fibronectin Fragment CH-296 in Combination With Interleukin-6, Stem Cell Factor, FLT-3 Ligand, and Megakaryocyte Growth and Development Factor

    Hans Peter Kiem;Hans Peter Kiem;Robert G. Andrews;Robert G. Andrews;Julia Morris;Julia Morris;Laura Peterson;Laura Peterson

  • Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

    H. Joachim Deeg;Barry Storer;John T. Slattery;Claudio Anasetti

  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

    Steven G. Deeks;Nancie Archin;Paula Cannon;Simon Collins

  • The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.

    Alexandre V. Hirayama;Jordan Gauthier;Kevin A. Hay;Kevin A. Hay;Jenna M. Voutsinas

  • Allogeneic hematopoietic stem cell transplantation for myelofibrosis

    H. Joachim Deeg;Theodore A. Gooley;Theodore A. Gooley;Mary E D Flowers;Mary E D Flowers;George E. Sale;George E. Sale

  • Duration of immunosuppressive treatment for chronic graft-versus-host disease.

    Betty L. Stewart;Barry Storer;Jan Storek;H. Joachim Deeg

  • Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD

    Afonso C. Vigorito;Paulo V. Campregher;Barry E. Storer;Paul A. Carpenter

  • Foamy virus vector integration sites in normal human cells

    Grant D. Trobridge;Daniel G. Miller;Michael A. Jacobs;James M. Allen

  • Polyclonal long-term repopulating stem cell clones in a primate model.

    Manfred Schmidt;Manfred Schmidt;Manfred Schmidt;Philipp Zickler;Philipp Zickler;Philipp Zickler;Gesa Hoffmann;Gesa Hoffmann;Gesa Hoffmann;Sebastian Haas;Sebastian Haas;Sebastian Haas

  • Gene Transfer into Marrow Repopulating Cells: Comparison Between Amphotropic and Gibbon Ape Leukemia Virus Pseudotyped Retroviral Vectors in a Competitive Repopulation Assay in Baboons

    Hans Peter Kiem;Hans Peter Kiem;Scott Heyward;Scott Heyward;Aaron Winkler;Aaron Winkler;Jennifer Potter;Jennifer Potter

  • Survival of the fittest: in vivo selection and stem cell gene therapy.

    Tobias Neff;Brian C. Beard;Hans Peter Kiem

Frequent Co-Authors

Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
David J. Rawlings
David J. Rawlings Seattle Children's Hospital
Richard A. Nash
Richard A. Nash Fred Hutchinson Cancer Research Center
Stanley R. Riddell
Stanley R. Riddell University of Washington
Cameron J. Turtle
Cameron J. Turtle Fred Hutchinson Cancer Research Center
H. Joachim Deeg
H. Joachim Deeg Fred Hutchinson Cancer Research Center
Brenda M. Sandmaier
Brenda M. Sandmaier Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Keith R. Jerome
Keith R. Jerome Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Understanding genetics opens the door to diverse healthcare careers, many of which require advanced education and specialized skills. For those interested in patient care or healthcare leadership, affordable online nursing degrees offer accessible pathways to rewarding careers. Students can compare the cheapest np school programs if they wish to become nurse practitioners, a role that combines clinical expertise with a deep understanding of genetics and human biology.

Accelerated programs are also available for those wanting to enter the workforce quickly. Exploring the cheapest accelerated nursing programs can help students balance financial considerations with speedy degree completion. For nurses aiming to advance into top-tier clinical or leadership positions, pursuing cheap online dnp programs can provide a cost-effective route to the highest level of nursing practice.

Additionally, registered nurses looking to enhance their credentials can benefit from cheap rn to bsn programs. These pathways not only promote career advancement but also align well with emerging trends in genomics and personalized medicine. By choosing an affordable and relevant degree, you can position yourself for success in a genetics-related healthcare field.

Best Scientists Citing Hans Peter Kiem

Trending Scientists

Recently Published Articles